Nalaganje...

Improved prognosis in gastric adenocarcinoma among metformin users in a population-based study

BACKGROUND: Metformin may improve the prognosis in gastric adenocarcinoma, but the existing literature is limited and contradictory. METHODS: This was a Swedish population-based cohort study of diabetes patients who were diagnosed with gastric adenocarcinoma in 2005–2018 and followed up until Decemb...

Popoln opis

Shranjeno v:
Bibliografske podrobnosti
izdano v:Br J Cancer
Main Authors: Zheng, Jiaojiao, Santoni, Giola, Xie, Shao-Hua, Lagergren, Jesper
Format: Artigo
Jezik:Inglês
Izdano: Nature Publishing Group UK 2021
Teme:
Online dostop:https://ncbi.nlm.nih.gov/pmc/articles/PMC8292480/
https://ncbi.nlm.nih.gov/pubmed/33972744
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-021-01408-8
Oznake: Označite
Brez oznak, prvi označite!